John Bernstein, Clinical Scientist at Cambridge Cognition, explores the trends and exciting developments that were discussed at the 2022 Society for Neuroscience (SfN) conference.
A new system being developed by Cambridge Cognition with Innovate UK funding will provide a non-invasive, inexpensive means of accurately monitoring levels of pain by combining artificial intelligence technology and cognitive neuroscience.
Computerised testing brings an unprecedented ability to capture more detailed information about patient responses. This could provide novel insights into cognitive processes, and greater discriminatory power in predicting cognitive deficits and decline in Alzheimer's and other diseases.
The 2017 CANTAB Research Grant was once again overwhelmed with applications. All the research proposals received were such high quality it was another impossible task for our funding committee to review and narrow the proposals down. We received applications from across the globe from Hong Kong to Saint Lucia. But there could only be three awards.
Digital Health & Innovation Scientist, Matthew Hobbs explores what test re-test reliability is, how you would measure it and why it is important when choosing cognitive tests.
Cognition is essential for everyday functioning - here's why.